Indemnification by CRISPR. Each CRISPR Entity will jointly and severally indemnify, defend and hold harmless [[Nkarta:Organization]] and its Affiliates, and each of its and their respective employees, officers, directors and agents (each, a “[[Nkarta:Organization]] Indemnified Party”) from and against any and all Liabilities that any [[Nkarta:Organization]] Indemnified Party may be required to pay to one or more Third Parties to the extent resulting from or arising out of:

Indemnification by CRISPR. Each CRISPR Entity will jointly and severally indemnify, defend and hold harmless [[Organization A:Organization]] and its Affiliates, and each of its and their respective employees, officers, directors and agents (each, a “[[Organization A:Organization]] Indemnified Party”) from and against any and all Liabilities that any [[Organization A:Organization]] Indemnified Party may be required to pay to one or more Third Parties to the extent resulting from or arising out of:

Indemnification by CRISPR. CRISPR will indemnify, defend and hold harmless Vertex, its Affiliates, Sublicensees, Distributors and each of its and their respective employees, officers, directors and agents (each, a “Vertex Indemnified Party”) from and against any and all Liabilities that the Vertex Indemnified Party may be required to pay to one or more Third Parties to the extent resulting from or arising out of:

CRISPR Patents. As between the Parties, CRISPR will control and be responsible for all aspects of the Prosecution and Maintenance of CRISPR Patents (excluding Joint Patents).

CRISPR Covenants. CRISPR hereby covenants to [[Nkarta:Organization]] that, except as expressly permitted under this Agreement:

CRISPR Patents. As between the Parties, CRISPR will control and be responsible for all aspects of the Prosecution and Maintenance of CRISPR Patents (excluding Joint Patents).

CRISPR Covenants. CRISPR hereby covenants to [[Organization A:Organization]] that, except as expressly permitted under this Agreement:

To CRISPR. Vertex hereby grants to CRISPR the right to rely upon and a right to copy, access, and otherwise use, all Adverse Event information pertaining to each Product (except for any Alternative Product that is not Covered by and does not embody the Licensed Technology) as reasonably required in connection with the Development and Commercialization of products (including the Products to the extent permitted under the Co-Commercialization Agreement, if applicable), and Vertex shall, if requested by CRISPR, provide a signed statement that CRISPR may rely on, and the Regulatory Authority may access, in support of CRISPR’s application for Regulatory Approval of such products.

CRISPR Patents. CRISPR will control and be responsible for all aspects of the Prosecution and Maintenance of CRISPR Background Patents, CRISPR Program Patents and ​ Joint Program Patents. CRISPR will use Commercially Reasonable Efforts to Prosecute and Maintain all CRISPR Background Patents, CRISPR Program Patents and ​ Joint Program Patents.

CRISPR Covenants. CRISPR hereby covenants to Vertex that, except as expressly permitted under this Agreement: